院長紹介

山口　怜 – Yamaguchi Satoshi –

循環器内科医としての2011年より沖縄県の中核病院で勤務してきました。2016年から2年間、米国Cedars-Sinai Medical Centerで心エコー研究の研鑽を積みました。2019年から中頭病院で虚血性心疾患(心筋梗塞、狭心症)のカテーテルインターベンション治療をしています。心不全、バイオマーカー、心エコーの臨床研究を継続しており、福島県立医科大学糖尿病内分泌代謝内科の特別研究員として学術活動を継続しています。

沖縄県中部の患者様の健康寿命を延伸できますよう、沖縄市知花に運動療法、心臓リハビリ施設をそなえた内科クリニックを開業致します。どうぞよろしくお願い致します。

経歴

2004	獨協医科大学医学部医学科卒業
2004-2006	亀田総合病院初期研修医
2006-2010	亀田総合病院麻酔科
2011	豊見城中央病院内科
2012-2016	豊見城中央病院循環器内科
2016-2018	米国 Cedars-Sinai Medical Center, Heart Institute
2019	中頭病院循環器内科医員
2019-	福島県立医科大学特別研究員
2020	琉球大学医学部医学研究科卒業 (医学博士)
2020-2023	中頭病院循環器内科医長
20234	沖縄北あんしん内科クリニック院長

資格

医学博士

麻酔科標榜医

日本内科学会総合内科専門医

日本循環器学会専門医

日本心血管インターベンション学会専門医

心臓リハビリ指導士

業績

受賞

2017 ASE (Baltimore) 28th American Society of Echocardiography Top 25 Research Travel Award

原著論文

S. Yamaguchi, M. Maeda, K. Oba, G. Maimaituxun, O. Arasaki, S. Yagi, K. Kusunose, T. Soeki, H. amada, D. Fukuda, H. Masuzaki, M. Sata & M. Shimabukuro (2023). Sex differences in the association between epicardial adipose tissue volume and left atrial volume index, BMC Cardiovascular Disorders in Press.

S. Yamaguchi, M. Shimabukuro, A. Tanaka, T. Imai, S. Hiramitsu, N. Takahashi, T. Kadokami, M. Ajioka, M. Suzuki, , K. Node, & CANDLE Trial Investigators. (2022). Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial. Diabetes, Obesity & Metabolism. https://doi.org/10.1111/dom.14876

Y. Nakayama, S. Yamaguchi, Y. Shinzato, S. Okamoto, Millman, J. F., K. Yamashiro, N. Takemoto, T. Uema, K. Arakaki, M. Higa, H. Koizumi, M. Shimabukuro, & H. Masuzaki (2021). Retrospective exploratory analyses on gender differences in determinants for incidence and progression of diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Endocrine Journal, 68(6), 655–669.

S. Yamaguchi, K. Oba, M. Higa, O. Arasaki, & M. Shimabukuro (2020). Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus. Journal of Clinical Medicine Research, 9

S. Yamaguchi, Y. Otaki, B. Tamarappoo, J. Yoshida, H. Ikenaga, J. Friedman, D. Berman, D. Dey, T. Shiota, The association between epicardial adipose tissue thickness around the right ventricular free wall evaluated by transthoracic echocardiography and left atrial appendage function, Int. J. Cardiovasc. Imaging. 36 (2020) 585–593.

S. Yamaguchi, Y. Otaki, B.K. Tamarappoo, T. Ohira, H. Ikenaga, J. Yoshida, T. Chakravarty, J. Friedman, D. Berman, F. Rader, R.J. Siegel, R. Makkar, T. Shiota, The Impact of Valvuloarterial Impedance on Left Ventricular Geometrical Change after Transcatheter Aortic Valve Replacement: A Comparison between Valvuloarterial Impedance and Mean Pressure Gradient, J. Clin. Med. Res. 9 (2020) 3143.

Y. Matsue, M. Suzuki, W. Nagahori, K. Yoshida, Y. Onishi, Y. Satoh, Y. Ono, T. Nishioka, M. Noda, K. Sugi, S. Torii, T. Tejima, H. Sakurada, S. Yamaguchi, K. Okishige, H. Fujii, A. Takahashi, Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study, Cardiovasc. Drugs Ther. 28 (2014) 73–77.

Y. Matsue, M. Suzuki, S. Torii, S. Yamaguchi, S. Fukamizu, Y. Ono, H. Fujii, T. Kitai, T. Nishioka, K. Sugi, Y. Onishi, M. Noda, N. Kagiyama, Y. Satoh, K. Yoshida, S.R. Goldsmith, Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction, Int. J. Cardiol. 221 (2016) 188–193.

Y. Matsue, M. Suzuki, S. Torii, S. Yamaguchi, S. Fukamizu, Y. Ono, H. Fujii, T. Kitai, T. Nishioka, K. Sugi, Y. Onishi, M. Noda, N. Kagiyama, Y. Satoh, K. Yoshida, S.R. Goldsmith, Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction, J. Card. Fail. 22 (2016) 423–432.

Y. Matsue, K. Yoshioka, M. Suzuki, S. Torii, S. Yamaguchi, S. Fukamizu, Y. Ono, H. Fujii, T. Kitai, T. Nishioka, K. Sugi, Y. Onishi, M. Noda, N. Kagiyama, Y. Satoh, K. Yoshida, S.R. Goldsmith, Prognostic importance of sodium level trajectory in acute heart failure, Heart Vessels. 32 (2017) 1498–1505.

Y. Matsue, M. Suzuki, S. Torii, S. Yamaguchi, S. Fukamizu, Y. Ono, H. Fujii, T. Kitai, T. Nishioka, K. Sugi, Y. Onishi, M. Noda, N. Kagiyama, Y. Satoh, K. Yoshida, S.R. Goldsmith, Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction, J. Card. Fail. 22 (2016) 423–432.

症例報告

S. Yamaguchi, N. Nadoyama, K. Kinjo, N Yagi, H. Ishimori, & M. Shimabukuro (2023). The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension. Cureus, 15(6), e40609.

S. Yamaguchi , & M. Shimabukuro, (2022). Acute Myocardial Infarction During the Last Part of a Triathlon: A Case Report. Cureus, 14(12), e32768.

S. Yamaguchi, K. Nakamura, O. Kobayashi, Y. Takahashi, K. Sato, M. Shimabukuro, Protective effect of remifentanil on blood loss in endoscopic subcutaneous mastectomy: a retrospective study, Ain-Shams Journal of Anesthesiology. 10 (2018) 8.

S. Yamaguchi, M. Kakazu, A. Osamu, Intestinal cholesterol embolism resulting from intra-aortic balloon pumping: a case report, J. Med. Case Rep. 8 (2014) 213.

S. Yamaguchi, M. Tabuchi, K. Oba, H. Doi, O. Arasaki, Fibrin glue patch for pacemaker lead perforation of the right ventricular free wall: A case report, HeartRhythm Case Rep. 2 (2016) 80–82.

和文総説

山口怜, 島袋充生 (2021) チアゾリン薬と心不全. 糖尿病内分泌代謝科, 52(3):242